Drug Shortage Report for PIPERACILLIN AND TAZOBACTAM FOR INJECTION

Last updated on 2018-05-16 History
Report ID 48144
Drug Identification Number 02401320
Brand name PIPERACILLIN AND TAZOBACTAM FOR INJECTION
Common or Proper name Piperacillin and Tazobactam for Injection
Company Name HIKMA CANADA LIMITED
Market Status DORMANT
Active Ingredient(s) PIPERACILLIN TAZOBACTAM
Strength(s) 3G 0.375G
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAVENOUS
Packaging size 3.375 G/VIAL
ATC code J01CR
ATC description BETA-LACTAM ANTIBACTERIALS, PENICILLINS
Reason for shortage Shortage of an active ingredient.
Anticipated start date
Actual start date 2018-04-24
Estimated end date 2018-05-10
Actual end date 2018-05-14
Shortage status Resolved
Updated date 2018-05-16
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 5995 AVEBURY ROAD, SUITE 804
MISSISSAUGA, ONTARIO
CANADA L5R 3P9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2018-05-02 English Compare
v2 2018-05-02 French Compare
v3 2018-05-09 English Compare
v4 2018-05-09 French Compare
v5 2018-05-16 English Compare
v6 2018-05-16 French Compare

Showing 1 to 6 of 6